Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
7.22
+0.33 (4.79%)
At close: Jun 6, 2025, 4:00 PM
7.54
+0.32 (4.43%)
After-hours: Jun 6, 2025, 5:41 PM EDT

Jade Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Selling, General & Admin
8.61
Research & Development
55.87
Operating Expenses
64.48
Operating Income
-64.48
Interest & Investment Income
2.32
Other Non Operating Income (Expenses)
-25.2
EBT Excluding Unusual Items
-87.36
Other Unusual Items
-6.6
Pretax Income
-93.96
Net Income
-93.96
Net Income to Common
-93.96
Shares Outstanding (Basic)
5
Shares Outstanding (Diluted)
5
EPS (Basic)
-18.79
EPS (Diluted)
-18.79
EBIT
-64.48
Source: S&P Global Market Intelligence. Standard template. Financial Sources.